A detailed history of Dafna Capital Management LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 1,419,262 shares of GOSS stock, worth $1.22 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,419,262
Previous 1,409,262 0.71%
Holding current value
$1.22 Million
Previous $1.27 Million 10.8%
% of portfolio
0.36%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.79 - $1.25 $7,900 - $12,500
10,000 Added 0.71%
1,419,262 $1.41 Million
Q1 2024

May 15, 2024

SELL
$0.8 - $1.51 $53,432 - $100,852
-66,790 Reduced 4.52%
1,409,262 $1.66 Million
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.82 $1.15 Million - $2.69 Million
1,476,052 New
1,476,052 $1.23 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.